Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis

[1]  Mikhail G Dozmorov,et al.  Epigenomic functional characterization of genetic susceptibility variants in systemic vasculitis. , 2016, Journal of autoimmunity.

[2]  Paul A. Renauer,et al.  Epigenetics and Vasculitis: a Comprehensive Review , 2016, Clinical Reviews in Allergy & Immunology.

[3]  P. Merkel,et al.  Neutrophil‐Related Gene Expression and Low‐Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis , 2015, Arthritis & rheumatology.

[4]  M. Resche-Rigon,et al.  Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients. , 2014, Autoimmunity reviews.

[5]  M. Segelmark,et al.  A myelopoiesis gene signature during remission in anti‐neutrophil cytoplasm antibody‐associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy , 2014, Clinical and experimental immunology.

[6]  C. Kallenberg,et al.  Differential Expression of Granulopoiesis Related Genes in Neutrophil Subsets Distinguished by Membrane Expression of CD177 , 2011, PloS one.

[7]  T. Kurza,et al.  A myelopoiesis gene signature during remission in ANCA associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy , 2014 .

[8]  Aarno Palotie,et al.  Genome-wide methylation analyses of primary human leukocyte subsets identifies functionally important cell-type-specific hypomethylated regions. , 2013, Blood.

[9]  R. Kettritz,et al.  The neutrophil in antineutrophil cytoplasmic autoantibody‐associated vasculitis , 2013, Journal of leukocyte biology.

[10]  P. Heeringa,et al.  Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. , 2013, The Journal of clinical investigation.

[11]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[12]  Yichun Hu,et al.  High Basal Activity of the PTPN22 Gain-of-Function Variant Blunts Leukocyte Responsiveness Negatively Affecting IL-10 Production in ANCA Vasculitis , 2012, PloS one.

[13]  C. Alpers,et al.  Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice with a Humanized Immune System , 2012, PloS one.

[14]  B. Bonaci-Nikolic,et al.  Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis , 2012, Clinical chemistry and laboratory medicine.

[15]  Y. Koh,et al.  Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity , 2012, Tumor Biology.

[16]  P. Merkel,et al.  Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. , 2011, Journal of the American Society of Nephrology : JASN.

[17]  Ming-hui Zhao,et al.  Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. , 2010, Kidney international.

[18]  T. Magnuson,et al.  Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. , 2010, The Journal of clinical investigation.

[19]  A. Bengtsson,et al.  Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression , 2010, Clinical and experimental immunology.

[20]  Chris Cheadle,et al.  Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis. , 2010, Arthritis and rheumatism.

[21]  Mikael Sigvardsson,et al.  Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells. , 2010, Blood.

[22]  C. Kallenberg,et al.  Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils. , 2009, Arthritis and rheumatism.

[23]  S. Nozell,et al.  The ING4 Tumor Suppressor Attenuates NF-κB Activity at the Promoters of Target Genes , 2008, Molecular and Cellular Biology.

[24]  L. Guillevin,et al.  Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. , 2008, Arthritis and rheumatism.

[25]  R J Falk,et al.  Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis. , 2007, Kidney international.

[26]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[27]  M. Wellner,et al.  NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. , 2007, Blood.

[28]  Kenneth G. C. Smith,et al.  Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification , 2007, BMC Genomics.

[29]  James A. Cuff,et al.  A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.

[30]  Stephan Sauer,et al.  Chromatin signatures of pluripotent cell lines , 2006, Nature Cell Biology.

[31]  Song Tan,et al.  ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. , 2006, Molecular cell.

[32]  Jianwen Cai,et al.  Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic AntibodyAssociated Small-Vessel Vasculitis , 2005, Annals of Internal Medicine.

[33]  William Arbuthnot Sir Lane,et al.  A Human Protein Complex Homologous to the Drosophila MSL Complex Is Responsible for the Majority of Histone H4 Acetylation at Lysine 16 , 2005, Molecular and Cellular Biology.

[34]  G. Sturfelt,et al.  Increased monocyte transcription of the proteinase 3 gene in small vessel vasculitis , 2005, Clinical and experimental immunology.

[35]  T. Colby,et al.  Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. , 2004, Blood.

[36]  D. Alcorta,et al.  Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. , 2004, Journal of the American Society of Nephrology : JASN.

[37]  Y. Kluger,et al.  Gene expression in human neutrophils during activation and priming by bacterial lipopolysaccharide , 2003, Journal of cellular biochemistry.

[38]  A. Busjahn,et al.  Membrane expression of proteinase 3 is genetically determined. , 2003, Journal of the American Society of Nephrology : JASN.

[39]  D. Alcorta,et al.  Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA). , 2002, Kidney international.

[40]  P. Heeringa,et al.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. , 2002, The Journal of clinical investigation.

[41]  P. Heeringa,et al.  Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. , 2001, The American journal of pathology.

[42]  F. Luft,et al.  Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. , 2001, Journal of the American Society of Nephrology : JASN.

[43]  S. Weissman,et al.  Global analysis of neutrophil gene expression , 2000, Current opinion in hematology.

[44]  J. Cowland,et al.  The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules , 1999, Journal of leukocyte biology.

[45]  B. Prum,et al.  A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. , 1999, Journal of the American Society of Nephrology : JASN.

[46]  V. Witko-Sarsat,et al.  Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool , 1995, FEBS letters.

[47]  R. Moots,et al.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. , 1994, QJM : monthly journal of the Association of Physicians.

[48]  M. Ernst,et al.  Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo , 1994, Clinical and experimental immunology.

[49]  M. Daha,et al.  Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. , 1993, Blood.

[50]  S. Mizel,et al.  Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. , 1991, The Journal of clinical investigation.

[51]  B. Dewald,et al.  Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8 , 1991, The Journal of experimental medicine.

[52]  R J Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.